Picture CRISPR-Cas9, a gene editing technology, as a GPS-guided scalpel: gRNA directs the Cas9 enzyme, a protein that cuts ...
Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.
CRISPR Therapeutics' Casgevy, the first CRISPR/Cas9 gene editing therapy, shows promising results in treating Sickle Cell Disease and beta thalassemia but faces challenges in patient adoption and cost ...
Integrated screening and CRISPR reveal eleven previously unknown factors essential for early embryo development. They showed ...
Restricted access to genome-editing technologies poses serious challenges for countries like India that urgently need such ...
CRISPR–Cas9-based therapies are widely investigated for their clinical applications. However, there are limitations ...
Whales with a lot of money to spend have taken a noticeably bearish stance on CRISPR Therapeutics. Looking at options history for CRISPR Therapeutics (NASDAQ:CRSP) we detected 13 trades. If we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback